Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 811.50
-24.75 (-2.96%)
Oct 23, 2026, 3:29 PM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 65.31 billion as of October 22, 2026. It is the 12,076th most valuable company in the world and the 715th biggest in India. Its market cap has increased by 7.60% in one year.
Market Cap
65.31B
Enterprise Value
64.58B
Revenue
8.73B
Global Rank
Country Rank
#715 India
PE Ratio
32.92
ChartMarket Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 65.31B, an increase of 107.62%. That is a compound annual growth rate of 16.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 65.31B | 7.98% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 553.62B |
| Anthem Biosciences | 455.34B |
| OneSource Specialty Pharma | 156.71B |
| Concord Biotech | 134.52B |
| Blue Jet Healthcare | 96.05B |
| Zota Health Care | 47.10B |
| Dishman Carbogen Amcis | 22.86B |
| Panacea Biotec | 21.38B |